Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Short Interest Down 75.5% in December

Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) was the target of a large drop in short interest during the month of December. As of December 31st, there was short interest totaling 8,630 shares, a drop of 75.5% from the December 15th total of 35,213 shares. Approximately 1.0% of the company’s shares are short sold. Based on an average daily volume of 26,165 shares, the short-interest ratio is currently 0.3 days. Based on an average daily volume of 26,165 shares, the short-interest ratio is currently 0.3 days. Approximately 1.0% of the company’s shares are short sold.

Virtus LifeSci Biotech Clinical Trials ETF Price Performance

Shares of BBC stock opened at $39.01 on Tuesday. The stock has a 50 day moving average price of $36.76 and a 200 day moving average price of $28.87. Virtus LifeSci Biotech Clinical Trials ETF has a 52-week low of $13.42 and a 52-week high of $40.82.

About Virtus LifeSci Biotech Clinical Trials ETF

The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.